However, most studies only focused on total CD8+ or CD4+ T cells, and exploration of the immunophenotypes of T cell subsets remains limited for CML patients, particularly TKI-F patients. The gene discussed is CD8A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.